LYRIC PHARMACEUTICALS INC has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals are MENDOZA WENDELL G, ONCORENA AB and BAKULESH MAFATLAL KHAMAR.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | Singapore | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | James Joyce | 11 |
#2 | Harris M Scott | 11 |
#3 | Wurtman David | 11 |
#4 | David Wurtman | 1 |
#5 | M Scott Harris | 1 |
#6 | Joyce James | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017197328A1 | Treatment of enteral feeding intolerance and muscle wasting with relamorelin | |
WO2017197131A1 | Treatment of enteral feeding intolerance and muscle wasting | |
WO2017083882A1 | Treatment of enteral feeding intolerance and other conditions using ulimorelin analogs | |
CN107106636A | The treatment that enteral feed is not tolerated |